Clinical trial

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

NCT04674332

Study summary

ClinicalTrials.gov

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Long acting insulin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention multiple dose regimen Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-09-01

PhasePHASE2 / PHASE3

Conditions

Long Acting Insulin in Control of Gestational Diabetes Mellitusunresolved

Interventions

Long acting insulinDRUG

multiple dose regimenDRUG

Sponsors & collaborators

Ain Shams Universitylead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04674332 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.